Our value Proposition
Our value Proposition
Impact through deep domain expertise.
Impact through deep domain expertise.
- Why choose us Why choose us Why choose us Why choose us Why choose us Why choose us
- Why choose us Why choose us Why choose us Why choose us Why choose us Why choose us
- Why choose us Why choose us Why choose us Why choose us Why choose us Why choose us
- Why choose us Why choose us Why choose us Why choose us Why choose us Why choose us
- Why choose us Why choose us Why choose us Why choose us Why choose us Why choose us
- Why choose us Why choose us Why choose us Why choose us Why choose us Why choose us
Integrated BioPharma strategy, BD & deal support
We connect asset strategy, BD pipeline and deal structuring into one coherent flow. Instead of separate “consulting”, “intro” and “transaction” efforts, you get a single partner who helps define where the asset fits, which counterparties matter, how to approach them, and what structures and economics make sense. That line of sight from strategy to meetings, term sheets and execution is at the core of our proposal.
Integrated BioPharma strategy, BD & deal support
We connect asset strategy, BD pipeline and deal structuring into one coherent flow. Instead of separate “consulting”, “intro” and “transaction” efforts, you get a single partner who helps define where the asset fits, which counterparties matter, how to approach them, and what structures and economics make sense. That line of sight from strategy to meetings, term sheets and execution is at the core of our proposal.
Integrated BioPharma strategy, BD & deal support
We connect asset strategy, BD pipeline and deal structuring into one coherent flow. Instead of separate “consulting”, “intro” and “transaction” efforts, you get a single partner who helps define where the asset fits, which counterparties matter, how to approach them, and what structures and economics make sense. That line of sight from strategy to meetings, term sheets and execution is at the core of our proposal.
Evidence-led, partner-ready positioning
Everything we do is anchored in how sophisticated pharma, payers and investors evaluate risk and value. We translate your science and clinical plan into a partner-ready package: clear TPP, indication and market thesis, realistic access view and structured materials for BD and diligence. This makes conversations more concrete, reduces noise in feedback and increases the probability that interest turns into structured options.
Evidence-led, partner-ready positioning
Everything we do is anchored in how sophisticated pharma, payers and investors evaluate risk and value. We translate your science and clinical plan into a partner-ready package: clear TPP, indication and market thesis, realistic access view and structured materials for BD and diligence. This makes conversations more concrete, reduces noise in feedback and increases the probability that interest turns into structured options.
Evidence-led, partner-ready positioning
Everything we do is anchored in how sophisticated pharma, payers and investors evaluate risk and value. We translate your science and clinical plan into a partner-ready package: clear TPP, indication and market thesis, realistic access view and structured materials for BD and diligence. This makes conversations more concrete, reduces noise in feedback and increases the probability that interest turns into structured options.
Hands-on execution with cross-border access
We do not just advise from the sidelines. We help build and run the BD pipeline, coordinate outreach around key catalysts, support negotiations and governance design, and keep internal stakeholders aligned on risks and trade-offs. With cross-border reach into relevant BD&L, corporate and investment teams, we plug you into the right rooms and ensure you show up prepared, consistent and credible.
Hands-on execution with cross-border access
We do not just advise from the sidelines. We help build and run the BD pipeline, coordinate outreach around key catalysts, support negotiations and governance design, and keep internal stakeholders aligned on risks and trade-offs. With cross-border reach into relevant BD&L, corporate and investment teams, we plug you into the right rooms and ensure you show up prepared, consistent and credible.
Hands-on execution with cross-border access
We do not just advise from the sidelines. We help build and run the BD pipeline, coordinate outreach around key catalysts, support negotiations and governance design, and keep internal stakeholders aligned on risks and trade-offs. With cross-border reach into relevant BD&L, corporate and investment teams, we plug you into the right rooms and ensure you show up prepared, consistent and credible.
How we can help
How we can help
More than a deal advisor, we’re your growth partner.
More than a deal advisor, we’re your growth partner.
Kristoffer Danielsson
Founder
Kristoffer Danielsson
Founder
Kristoffer Danielsson
Founder
Your questions, our expert answers
Your questions, our expert answers
01.
At what stage of development does it make sense to work with Jarlen Capital?
02.
Do you only work with biotech companies, or also with pharma and investors?
03.
How do you typically engage, project-based, ongoing support, or as an extended BD function?
04.
How is your work different from what a bank, broker, or generic consulting firm would do?
01.
At what stage of development does it make sense to work with Jarlen Capital?
02.
Do you only work with biotech companies, or also with pharma and investors?
03.
How do you typically engage, project-based, ongoing support, or as an extended BD function?
04.
How is your work different from what a bank, broker, or generic consulting firm would do?
At what stage of development does it make sense to work with Jarlen Capital?
Do you only work with biotech companies, or also with pharma and investors?
How do you typically engage, project-based, ongoing support, or as an extended BD function?
How is your work different from what a bank, broker, or generic consulting firm would do?
We align BioPharma innovation, capital, and strategy cross borders.
We connect visionary researchers and impact-driven investors to shape the future of healthcare.
We align BioPharma innovation, capital, and strategy cross borders.
We connect visionary researchers and impact-driven investors to shape the future of healthcare.
We align BioPharma innovation, capital, and strategy cross borders.
We connect visionary researchers and impact-driven investors to shape the future of healthcare.